Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, October 21, 2014
 
Register | Sign in
Home Page>Products
  Product News
Malvern Technology Delivers Malvern Reliability in Multi-disciplinary Lab
Wednesday, September 10, 2014
The Zetasizer Nano, NanoSight NTA and Mastersizer 2000 systems employed within the Queen Mary University London lab.

Abzena Appoints Experts for Relocation to New Headquarters
Wednesday, September 10, 2014
Laboratory relocation specialist Andrew Porter Limited has completed the move of PolyTherics, a wholly owned subsidiary of Abzena, to the Babraham Research Campus in Cambridge.

Diagnostic Tool for Therapeutic Plasma Medicine
Tuesday, September 09, 2014
HPR-60 mass spectrometer for direct measurement of reactive and gaseous species.

Titan Enterprises Reports Growth in Flow Meter Exports
Tuesday, September 09, 2014
Company saw record production of over 45,000 flow meters.

New GC-MS Runs Both Single and Triple Quadrupole Methods Using Familiar Software
Monday, September 08, 2014
Labs have new option with the Thermo Scientific TSQ Duo triple quadrupole GC-MS/MS system.

Meet SeedEZ, a universal 3D cell culture drug screening system
Sunday, September 07, 2014
Lena Biosciences introduces a robust and easy to use SeedEZ 3D cell culture drug screening system supporting consistent yet complex 3D cell culture, co-culture and multilayered tissue models with immune and inflammatory components.

Precision Fluid Control for Food & Beverage Ingredient Additions
Saturday, September 06, 2014
Valveless metering pumps from Fluid Metering.

Bioo Scientific Features Sensitive Food Safety Solutions at AOAC 2014
Saturday, September 06, 2014
Company will showcase the MaxSignal® Aflatoxin M1 ELISA Kit, the AuroFlow™ Aflatoxin M1 Strip Test Kit and the AflaPure™ Aflatoxin M1 Column Kit.

City Launches New Long-life O2 and Emissions Sensors at MICONEX
Saturday, September 06, 2014
MICONEX show in Beijing, China from 23-26 September.

<< 9 10 11 12 13 14 15 >>
Showing Results 111 - 120 of 10580
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv